5kits zhao

Calendar

January 2011
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Pages

Archives

Blogroll






 Escape From PTSD

By Rick Nauert PhD Senior News Editor
Reviewed by John M. Grohol, Psy.D. on July 20, 2010 

New research suggests MDMA, aka Ecstasy, in combination with psychotherapy may help individuals with treatment-resistant PTSD.

A recent clinical trial reports that MDMA can be administered to subjects with PTSD without evidence of harm.

The intervention could reduce fear responses among individuals thereby creating an environment where psychotherapy could be more beneficial.

The results of the clinical trial are published in the Journal of Psychopharmacology.

Before MDMA became used recreationally under the street name Ecstasy, hundreds of psychiatrists and psychotherapists around the world administered MDMA as a catalyst to psychotherapy.

MDMA was criminalized in the U.S. in 1985 (it had been illegal in the UK since 1977).

Several decades later, this study is the first completed randomized, double-blinded clinical trial to evaluate MDMA as a therapeutic adjunct in any patient population.

Belmont, Mass.-based Rick Doblin, Ph.D., together with South Carolina-based psychiatrist Michael Mithoefer, MD and colleagues, conducted a pilot Phase II clinical trial with 20 patients with chronic PTSD persisting for an average of over 19 years.

Prior to enrolling in the MDMA study, subjects were required to have received, and failed to obtain relief, from both psychotherapy and psychopharmacology.

Read in Full:  http://psychcentral.com/news/2010/07/20/therapy-plus-ecstasy-for-ptsd/15791.html

 



Leave a Reply

*